Update your browser

Your browser (Internet Explorer) is out of date.

Update your browser for more security, comfort and the best experience on this site.

Pharsight Corporation

Certara the leading provider of drug discovery informatics products and services, with the Pharsight Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development.

100 Mathilda Place, Suite 160, Sunnyvale, CA 94086, United States

Profile Navigation
This is a community generated profile. If you would like to claim it, please contact us.

About

Our Company

Certara® was formed in 2008 by the merger of Tripos® International, the leading provider of drug discovery informatics products and services, with the Pharsight® Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development. In 2012, the ability to provide innovation solutions to the pharmaceutical industry was further augmented with the acquisition of Simcyp® Limited, the leading research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations. The following year, the acquisition of Great Lakes Drug Development, Inc further increased the depth of Certara’s early drug development analysis, modeling and simulation expertise.

Company Type

Choose Company Type

Cancel

Company Size

< 10

Choose Company Size

Cancel

Contact Info

get in touch

  • Location:

    Other: 100 Mathilda Place, Suite 160, Sunnyvale, CA 94086, United States